Alzheimer's Disease Trial, Recruiting NCT07425769 Sponsor: University of Kansas Medical Center Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07425769
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

For adults with Down syndrome:

Who might be able to join this trial:

  • People aged 35 or older who have Down syndrome (as reported by themselves or their caregiver)
  • People who can understand instructions and communicate their needs, wants, and preferences through spoken language
  • People who live at home or in a supported living setting with a parent or caregiver who is willing to take part in the study alongside them
  • People who feel they are able to take part in physical activity

Who may not be able to join:

  • People who are not able to take part in moderate-to-vigorous physical activity
  • People who have a self-reported heart, metabolic (such as diabetes), or kidney condition, or who have symptoms that may suggest one of these conditions (confirm with trial site)

For caregivers:

Who might be able to join this trial:

  • People aged 18 or older
  • People who are the primary caregiver of an adult with Down syndrome
  • People who speak English
  • People who feel they are able to take part in physical activity

Who may not be able to join:

  • People who are not able to take part in moderate physical activity, such as brisk walking
  • People who have a self-reported heart, metabolic (such as diabetes), or kidney condition, or who have symptoms that may suggest one of these conditions (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 913-574-2447

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Kansas Medical Center
Registry
ClinicalTrials.gov
Start date
31 March 2026
Est. completion
31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility: Participant Recruitment; Feasibility: Recruitment Rate; Feasibility: Participant retention; Feasibility: Session Attendance; Feasibility: Participant Safety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov